Data from Phase 1b/2 clinical trial to be presented at 2024 San Antonio Breast Cancer Symposium (SABCS) show encouraging clinical activity in ...
News
- ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with ... - Morningstar
- UTSA's Stanton F. McHardy named fellow of National Academy of Inventors | UTSA Today
The CIDD is a collaborative initiative between UTSA and UT Health San Antonio. “I feel extremely honored to be included as an NAI fellow and have the ...
- Richmond-based BioAge sees stock fall over 70% after halting obesity drug clinical trial
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Bay Area biotech sells cancer drug for over $400 million. Related ...
- Houston Medicine Magazine Headlines Powered By Business Wire
... San Antonio Breast Cancer Symposium. 12/09/2024 - 08:05 AM. View Press Release · DNAnexus and Panomics Join Forces to Deliver Comprehensive ...
- Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium - BioSpace
(NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced it will present new data at the 2024 San Antonio Breast Cancer ...